Harbour Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.32M Sell
22,964
-400
-2% -$23K 0.68% 43
2026
Q1
$1.42M Sell
23,364
-1,629
-7% -$95K 0.77% 42
2025
Q4
$1.35M Sell
24,993
-1,855
-7% -$89.2K 0.71% 42
2025
Q3
$1.21M Sell
26,848
-3,490
-12% -$163K 0.53% 51
2025
Q2
$1.4M Buy
30,338
+718
+2% +$35.2K 0.61% 49
2025
Q1
$1.81M Sell
29,620
-250
-0.8% -$14.6K 0.82% 41
2024
Q4
$1.69M Sell
29,870
-7,570
-20% -$423K 0.74% 42
2024
Q3
$1.94M Buy
37,440
+3,255
+10% +$153K 0.86% 39
2024
Q2
$1.42M Buy
34,185
+915
+3% +$40.9K 0.66% 45
2024
Q1
$1.8M Buy
33,270
+8,390
+34% +$427K 0.85% 42
2023
Q4
$1.28M Sell
24,880
-2,930
-11% -$154K 0.67% 45
2023
Q3
$1.61M Sell
27,810
-100
-0.4% -$6.13K 0.92% 39
2023
Q2
$1.78M Sell
27,910
-50
-0.2% -$3.35K 0.94% 40
2023
Q1
$1.94M Buy
27,960
+2,845
+11% +$201K 1.07% 38
2022
Q4
$1.81M Buy
25,115
+300
+1% +$22.6K 1.04% 40
2022
Q3
$1.76M Buy
24,815
+1,005
+4% +$72.9K 1.1% 38
2022
Q2
$1.83M Sell
23,810
-1,200
-5% -$91.4K 1.1% 40
2022
Q1
$1.83M Sell
25,010
-551
-2% -$37K 0.89% 43
2021
Q4
$1.59M Buy
25,561
+2,571
+11% +$151K 0.73% 43
2021
Q3
$1.36M Buy
+22,990
New +$1.51M 0.69% 42

Other funds holding BMY

Harbour Investment Management's BMY Position: Q2 2026 in Review

Harbour Investment Management reduced its Bristol-Myers Squibb (BMY) stake by 1.7% in Q2 2026, selling an estimated $23K and leaving 22,964 shares worth $1.32M. The position accounts for 0.68% of the portfolio, ranked #43.

Harbour Investment Management first reported a position in BMY in Q3 2021 and has held it in 20 quarters since. The position peaked at $1.94M in Q1 2023. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Harbour Investment Management held 22,964 shares of Bristol-Myers Squibb worth $1.32M as of Q2 2026.
  • Harbour Investment Management sold 400 Bristol-Myers Squibb shares in Q2 2026, an estimated $23K.
  • Bristol-Myers Squibb made up 0.68% of Harbour Investment Management's portfolio in Q2 2026, its #43 holding.
  • Harbour Investment Management first reported a position in Bristol-Myers Squibb in Q3 2021 and has held it in 20 quarters since.
  • Harbour Investment Management's Bristol-Myers Squibb position peaked at $1.94M in Q1 2023.
  • 796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Harbour Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.